Prophylaxis of radiation-induced nausea and vomiting using 5-hydroxytryptamine-3 serotonin receptor antagonists: A systematic review of randomized trials

International Journal of Radiation Oncology Biology Physics

Volumn 82, Issue 1, 2012, Pages 408-417

  Salvo, Nadia ^a   Doble, Brett ^a   Khan, Luluel ^b   Amirthevasar, Gayathri ^a   Dennis, Kristopher ^b   Pasetka, Mark ^c   Deangelis, Carlo ^c   Tsao, May ^b   Chow, Edward ^b  

^a MCMASTER UNIVERSITY   (Canada)

^b DEPARTMENT OF RADIATION ONCOLOGY   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

5 HT3 receptor antagonist; Radiation induced nausea and vomiting; Systematic review

Indexed keywords

CHEMOTHERAPY; CONTROLLED DRUG DELIVERY; DIAGNOSIS; GRADING; INVERSE PROBLEMS; RANDOM PROCESSES;

CONFIDENCE INTERVAL; ELECTRONIC DATABASE; EVALUATION APPROACH; METHODS AND MATERIALS; RADIATION-INDUCED; RANDOM EFFECTS MODEL; RECEPTOR ANTAGONISTS; SYSTEMATIC REVIEW;

QUALITY CONTROL;

CHLORPROMAZINE; DEXAMETHASONE; DOLASETRON MESILATE; DOPAMINE RECEPTOR BLOCKING AGENT; GRANISETRON; METOCLOPRAMIDE; ONDANSETRON; PLACEBO; PROCHLORPERAZINE; SEROTONIN 3 ANTAGONIST; TROPISETRON;

ALOPECIA; CANCER PATIENT; CANCER RADIOTHERAPY; CHEMOTHERAPY INDUCED EMESIS; COCHRANE LIBRARY; CONSTIPATION; DRUG EFFICACY; DRUG SAFETY; DYSPHAGIA; EMBASE; HEADACHE; HUMAN; LOADING DRUG DOSE; MEDLINE; META ANALYSIS; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; QUALITY OF LIFE; RADIATION FIELD; RADIATION INDUCED EMESIS; RADIATION SICKNESS; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK ASSESSMENT; SYSTEMATIC REVIEW; UNSPECIFIED SIDE EFFECT; VERTIGO;

EID: 83955164327     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2010.08.060     Document Type: Article

References (27)

1. J.C. Horiot Prophylaxis versus treatment: Is there a better way to manage radiotherapy-induced nausea and vomiting? Int J Radiat Oncol Biol Phys 60 2004 1018 1025
2. R.K.S. Wong, N. Paul, and K. Ding 5-Hydroxytryptamine-3 receptor antagonist with or without short-course dexamethasone in the prophylaxis of radiation induced emesis: A placebo-controlled randomized trial of the National Cancer Institute of Canada Clinical Trials Group (SC19) J Clin Oncol 24 2006 3458 3464
3. Italian Group for Antiemetic Research in Radiotherapy Radiation-induced emesis: A prospective observational multicentre Italian trial Int J Radiat Oncol Biol Phys 44 1999 619 625
4. P. Kirkbride, A. Bejzak, and J. Pater Dexamethasone for the prophylaxis of radiation-induced emesis: A National Cancer Institute of Canada Clinical Trials Group phase III study J Clin Oncol 18 2000 1960 1966
5. A. Enblom, B.B. Axelsson, and G. Steineck One third of patients with radiotherapy-induced nausea consider their antiemetic treatment insufficient Support Care Cancer 17 2009 23 32
6. NCCN Clinical Practice Guidelines in Oncology Available at: http://www.nccn.org/professionals/physician-gls/f-guidelines.asp#supportive Accessed Jan 16, 2010
7. S.J. Gunning, R.M. Hagan, and M.B. Tyers Cisplatin induced biochemical and histological changes in the small intestine of the ferret Br J Pharmacol 90 1987 135P
8. R. Cunningham 5-HT3-receptor antagonists: A review of pharmacology and clinical efficacy Oncol Nurs Forum 24 1997 33 40
9. M. Aapro Review of experience with ondansetron and granisetron Ann Oncol 4 1993 S9 S14
10. T.R. Spitzer, C.J. Friedman, and W. Bushnell Double-bind, randomized, parallel-group study on the efficacy and safety of oral granisetron and oral ondansetron in the prophylaxis of nausea and vomiting in patients receiving hyperfractionated total body irradiation Bone Marrow Transplant 26 2000 203 210
11. R. Lanciano, D.M. Sherman, and J. Michalski The efficacy and saftey of once-daily kytril tablets in the prohylaxis of nausea and emesis following fractionated upper abdominal radiotherapy Cancer Invest 19 2001 763 772
12. I.T. Jantunen, V.V. Kataja, and T.T. Muhonen An overview of randomised studies comparting 5-HT3 receptor antagonists to conventional anti-emetics in the prophylaxis of acute chemotherapy-induced vomiting Eur J Cancer 33 1997 66 74
13. M.G. Kris, P.J. Hesketh, and M.R. Somerfield American Society of Clinical Oncology guideline for antiemetics in oncology: Update 2006 J Clin Oncol 24 2006 2932 2947
14. A.J. Sykes, A.E. Kiltie, and A.L. Stewart Ondansetron versus chlorpromazine and dexamethasone combination for the prevention of nausea and vomiting: A prospective, randomised study to assess efficacy, cost effectiveness and quality of life following single-fraction radiotherapy Support Care Cancer 5 1997 500 503
15. M.R. Tramr, D.J.M. Reynolds, and R.S. Stoner Efficacy of 5-HT3 receptor antagonists in radiotherapy-induced nausea and vomiting: A quantitative systematic review Eur J Cancer 34 1998 1836 1844
16. H.G. Prentice Granisetron in the control of nausea and vomiting associated with bone marrow transplantation: A review of its efficacy and tolerability Support Care Cancer 11 2003 501 508
17. G.H. Guyatt, A.D. Oxman, and R. Kunz What is "quality of evidence" and why is it important to clinicians? BMJ 336 2008 995 998
18. G.H. Guyatt, R. Drummond, and M. Meade Users' guides to the medical literature: A manual for evidence-based clinical practice 2nd ed. 2008 McGraw Hill New York
19. T.J. Priestman, J.T. Roberts, and R. Lucraft Results of a randomized, double-blind comparative study of ondansetron and metoclopramide in the prevention of nausea and vomiting following high-dose upper abdominal irradiation Clin Oncol 2 1990 71 75
20. The final assessment of a randomized double-blind comparative study of ondansetron vs metoclopramide in the prevention of nausea and vomiting following high-dose upper abdominal irradiation Clin Oncol (R Coll Radiol) 3 1991 241 242
21. S. Okkan, and A.L Tropisetron in the prevention of radiation-induced nausea and vomiting (Abstr.) Toxic Reduction 2001 1347
22. N. Aass, D.E. Htun, and M. Thorenson Prophylactic use of tropisetron or metoclopramide during adjuvant abdominal radiotherapy of seminoma stage I: A randomised, open trial in 23 patients Radiother Oncol 45 1997 125 128
23. P. Bey, P.M. Wilkinson, and M. Resbeut A double-blind, placebo-controlled trial of i.v. dolasetron mesilate in the prevention of radiotherapy-induced nausea and vomiting in cancer patients Support Care Cancer 4 1996 378 383
24. T.J. Priestman, J.T. Roberts, and B.K. Upadhyaya A prospective randomized double-blind trial comparing ondansetron versus prochlorperazine for the prevention of nausea and vomiting in patients undergoing fractionated radiotherapy Clin Oncology 5 1993 358 363
25. L. Franzén, J. Nyman, and H. Hagberg A randomised placebo controlled study with ondansetron in patients undergoing fractionated radiotherapy Ann Oncol 7 1996 586 592
26. Dincer M, Bilge N, Tmaz C. Tropisetron for prevention of nausea and vomiting induced by irradiation (Abstr.). 1995;1215.
27. P.J. Hesketh Chemotherapy-induced nausea and vomiting N Engl J Med 358 2008 2482 2494